BIODESIX INC — Director's Dealing 2020

Dec 10, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2020-12-07

Reporting Person: Strobeck Matthew (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-12-07	Common Stock	M	35157	$6.83	Acquired	943535	Direct
2020-12-07	Common Stock	M	23440	$6.83	Acquired	966975	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-12-07	Stock Options (Right to Buy)	$6.83	M	35157	Disposed	2029-07-15	Common Stock (35157)	Direct
2020-12-07	Stock Options (Right to Buy)	$6.83	M	23440	Disposed	2030-04-14	Common Stock (23440)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	40687	Indirect
Common Stock	3522	Indirect
Common Stock	3522	Indirect
Common Stock	3522	Indirect
Common Stock	3522	Indirect
Common Stock	72500	Indirect
Common Stock	10833	Indirect

Footnotes

F1: The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F2: The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F3: The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The shares reported herein as held by Birchview Fund, LLC and the shares reported held by Birchview Capital Separately Managed Account were always held for each respective account, but were inadvertently reported as all being held for Birchview Fund, LLC in the Form 4 filed on November 3, 2020. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

F4: This option vested in 12 successive, equal monthly installments measured from April 1, 2019.

F5: This option vests in 12 successive, equal monthly installments measured from April 1, 2020.